Literature DB >> 23350557

The Yazd Eye Study-a population-based survey of adults aged 40-80 years: rationale, study design and baseline population data.

Marzieh Katibeh1, Hossein Ziaei, Mohammad Pakravan, Mohammad H Dehghan, Alireza Ramezani, Haydar Amini, Shahin Yazdani, Reza Solaimanizad, Mehdi Yaseri, Mohammad Ali Javadi.   

Abstract

PURPOSE: To describe the rationale, methodology and baseline data of the Yazd Eye Study, a study in the urban and rural areas of Yazd, a district in the center of Iran.
METHODS: This population-based cross-sectional study included adults aged 40-80 years from the non-institutionalized population of the Yazd district, in 2010-2011. Using multi-stage, systematic cluster random sampling and a probability proportional to size strategy, 58 clusters of 40 subjects were selected from 251 clusters in different enumeration areas. A detailed interview and eye examination were performed for each eligible participant. The eye examination included refraction testing, uncorrected and best corrected visual acuity testing, slit lamp biomicroscopy, Goldmann applanation tonometry, gonioscopy, dilated fundus examination, visual field, determination of central corneal thickness, and stereoscopic fundus photography. General health assessments and laboratory tests including hemoglobin, hematocrit, glycosylated hemoglobin, fasting blood sugar, serum lipids, and urine albumin to creatinine ratio were also performed to assess anthropometric and systemic risk factors.
RESULTS: Of 2320 eligible individuals, 2098 (response rate 90.4%) participated in the study. The mean ± standard deviation age of participants was 54.1 ± 10.0 years, and included 994 men (47.4%) and 1104 women (52.6%). Most participants lived in urban regions (89.2%) and were younger than 60 years old (72.0%). Among the participants, 20.1% were illiterate, and 40.9%, 28.0%, and 11.0% had primary, secondary and college or university level education, respectively.
CONCLUSION: This study is expected to provide an estimate of the prevalence and risk factors of major eye diseases and normal eye indices in the Yazd district.

Entities:  

Mesh:

Year:  2013        PMID: 23350557     DOI: 10.3109/09286586.2012.744844

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  6 in total

1.  Awareness of the Necessity of Regular Eye Examinations among Diabetics: The Yazd Eye Study.

Authors:  Marzieh Katibeh; Hamid Ahmadieh; Ramin Beiranvand; Reza Soleimanizad; Mohammad Ali Javadi
Journal:  Int J Prev Med       Date:  2017-07-04

2.  The Association of Central Corneal Thickness with Ocular and General Parameters in a Community Setting: The Yazd Eye Study.

Authors:  Reza Soleimanizad; Mohammad Hosein Nowroozzadeh; Hossein Ziaei; Mohammad Pakravan; Mehdi Yaseri; Marzieh Katibeh
Journal:  J Ophthalmic Vis Res       Date:  2017 Apr-Jun

3.  The Shiraz Pediatric Eye Study; a Population Based Survey of School Age Children: Rationale, Design and Baseline Characteristics.

Authors:  Mohammad Reza Talebnejad; Mohammad Hossein Nowroozzadeh; Hamideh Mahdaviazad; Mohammad Reza Khalili; Masoumeh Beygom Masoumpour; Maryam Keshtkar; Elham Mohammadi; Zahra Tajbakhsh
Journal:  J Ophthalmic Vis Res       Date:  2018 Jul-Sep

4.  Prevalence of refractive errors; the yazd eye study.

Authors:  Hossein Ziaei; Marzieh Katibeh; Reza Solaimanizad; Sara Hosseini; Hamid-Reza Gilasi; Faegheh Golbafian; Mohammad-Ali Javadi
Journal:  J Ophthalmic Vis Res       Date:  2013-07

5.  Prevalence and Causes of Visual Impairment and Blindness in Central Iran; The Yazd Eye Study.

Authors:  Marzieh Katibeh; Mohammad Pakravan; Mehdi Yaseri; Mojgan Pakbin; Reza Soleimanizad
Journal:  J Ophthalmic Vis Res       Date:  2015 Jul-Sep

6.  Distribution of iris color and its association with ocular diseases in a rural population of Iran.

Authors:  Hassan Hashemi; Reza Pakzad; Abbasali Yekta; Fereshteh Shokrollahzadeh; Hadi Ostadimoghaddam; Hassan Mahboubipour; Mehdi Khabazkhoob
Journal:  J Curr Ophthalmol       Date:  2018-05-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.